BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Pappas Ventures names Michael Grey Venture Partner
News | 01. 11. 2010
Pappas Ventures today announced that industry veteran Michael Grey has been named a venture partner.
